Atara Biotherapeutics Inc (ATRA)
0.7339
+0.04
(+6.36%)
USD |
NASDAQ |
May 01, 14:13
Atara Biotherapeutics Total Liabilities (Quarterly): 264.74M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 264.74M |
| September 30, 2023 | 239.63M |
| June 30, 2023 | 238.98M |
| March 31, 2023 | 237.12M |
| December 31, 2022 | 249.78M |
| September 30, 2022 | 181.20M |
| June 30, 2022 | 178.64M |
| March 31, 2022 | 172.96M |
| December 31, 2021 | 188.51M |
| September 30, 2021 | 139.78M |
| June 30, 2021 | 125.25M |
| March 31, 2021 | 130.60M |
| December 31, 2020 | 125.78M |
| September 30, 2020 | 51.60M |
| June 30, 2020 | 46.99M |
| March 31, 2020 | 46.72M |
| December 31, 2019 | 52.16M |
| September 30, 2019 | 46.34M |
| June 30, 2019 | 41.86M |
| March 31, 2019 | 40.79M |
| December 31, 2018 | 52.98M |
| Date | Value |
|---|---|
| September 30, 2018 | 39.89M |
| June 30, 2018 | 40.21M |
| March 31, 2018 | 33.92M |
| December 31, 2017 | 39.92M |
| September 30, 2017 | 23.74M |
| June 30, 2017 | 23.01M |
| March 31, 2017 | 8.604M |
| December 31, 2016 | 10.18M |
| September 30, 2016 | 14.22M |
| June 30, 2016 | 10.57M |
| March 31, 2016 | 9.144M |
| December 31, 2015 | 9.875M |
| September 30, 2015 | 6.631M |
| June 30, 2015 | 11.85M |
| March 31, 2015 | 3.723M |
| December 31, 2014 | 2.94M |
| September 30, 2014 | 77.15M |
| June 30, 2014 | 2.28M |
| March 31, 2014 | 77.57M |
| December 31, 2013 | 62.84M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
41.86M
Minimum
Jun 2019
264.74M
Maximum
Dec 2023
145.19M
Average
139.78M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.72M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 15.52M |
| Oragenics Inc | 1.798M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.50M |
| Shareholders Equity (Quarterly) | -99.23M |
| Current Ratio | 0.7162 |